4Lewkowich I P, Hay Glass KT. Endogenous IFN-gamma and IL-18 production directly limit induction of type 2 immunity in vivo. Eur J Immunol. 2002, 32(12):3536.
6Xu D, Chan W L, Leung B P, et al. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med. 1998, 188(8):1485.
7Kobashi K, Iwagaki H, Yoshino T, et al. Down-regulation of IL-18 receptor in cancer patients: its clinical significance. Anticancer Res. 2001, 21(5):3285.
8Lauwerys B R, Rensuld J G, Houssiau F A. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. Cytokine. 1999, 11:822.
10Kikuchi T, Akssaki Y, Joki T, et al. Antitumor activity of interleukin-18 on mouse glioma cells. J Immunother. 2000, 23:184.
二级参考文献51
1Xu D，J Experiment Med，1998年，188卷，8期，1485页
2Gu Y，Science，1997年，275卷，206页
3Kikuchi T, Akasaki Y, Joki T et al.Antitumor activity of interleukin-18 on mouse glioma cells [J].J Immunother, 2000;23(2):184-189.
4Oshikawa K, Shi F, Rakhmilevich A L et al.Synergistie inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12 pro-IL-18 and IL-1 beta converting enzyme cDNA [J].Proc Natl Acad Sci USA,1999;96(23):13351
5Osaki T, Hashimoto W, Gambotto A et al.Potent anti-tumor effects mediated by local expression of the mature form of the interferon -gamma inducing factor interleukin -18(IL-18) [J].Gene Ther,1999;65(5):808-815.
6Yoshimura K, Hazama S, IiZuka N et al.Successful immunogene therapy using xolon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence [J].Cancer Gene Ther, 2001; 8(1):9-16.
7Kim J J, Yang J S, Dang K et al.Engineering enhancement of immune responses to DNA-based vaccines in a prostate cancer model in rhesus macaques through the use of cytokine gene adjuvants [J].Clin Cancer Res, 2001;7(3):s882-s889.
8Worrall NK, Chang K, LeJeune WS, et al. TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms [J]. Am J Physiol, 1997,273 (6 Pt 2): H2565-2574.
9Yao YM, Redl H, Bahrami S, et al. The inflammatory basis of trauma/shock-associated multiple organ failure [J]. Inflamm Res,1998,47(2) :79.
10Amiot F, Fitting C, Tracey KJ, et al. Lipopolysaccharide-induced cytokine cascade and lethality in LT alpha/TNF alpha-deficient mice[J]. Mol Med, 1997, 3(12): 864-875.
